Cas:76578-14-8 quizalofop-ethyl manufacturer & supplier

We serve Chemical Name:quizalofop-ethyl CAS:76578-14-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

quizalofop-ethyl

Chemical Name:quizalofop-ethyl
CAS.NO:76578-14-8
Synonyms:ethyl (2RS)-2-[4-(6-chloroquinoxalin-2-yloxy)phenoxy]propionate;rac-ethyl (2R)-2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate;MFCD00128062;ethyl 2-[4-[(6-chloro-2-quinoxalinyl)oxy]phenoxy]propanoate;Quizalofop-ethyl;Quizalofop ethyl
Molecular Formula:C19H17ClN2O4
Molecular Weight:372.80200
HS Code:2933399024

Physical and Chemical Properties:
Melting point:91.7-92.1ºC
Boiling point:503.9ºC at 760 mmHg
Density:1.301 g/cm3
Index of Refraction:1.604
PSA:70.54000
Exact Mass:372.08800
LogP:4.40590

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077
Packing Group:


Contact us for information like ethyl (2RS)-2-[4-(6-chloroquinoxalin-2-yloxy)phenoxy]propionate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Quizalofop ethyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,rac-ethyl (2R)-2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate Use and application,ethyl 2-[4-[(6-chloro-2-quinoxalinyl)oxy]phenoxy]propanoate technical grade,usp/ep/jp grade.


Related News: Health officials said it remained unclear where he had developed the disease. quizalofop-ethyl manufacturer Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. quizalofop-ethyl supplier Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2). quizalofop-ethyl vendor Health officials said it remained unclear where he had developed the disease. quizalofop-ethyl factory However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.